The North America Bioprocess Containers Market is witnessing significant growth driven by the increasing adoption of single-use technologies and rising demand for biopharmaceuticals. The market was valued at USD 1,320 Million in 2025 and is projected to reach USD 3,610 Million by 2035, growing at a CAGR of 9.5% from 2024 to 2035.
The economic impact of tariffs on "North America Bioprocess Containers Market".
Market Growth Drivers
Surging adoption of single-use bioprocess systems: Leading biopharmaceutical companies, such as GE Healthcare and Thermo Fisher Scientific, are increasingly integrating single-use bioprocess containers to improve scalability and reduce cross-contamination risk. This shift is motivated by the flexibility and cost-effectiveness afforded by disposable solutions in cGMP (current Good Manufacturing Practice) environments. Furthermore, the rising demand for rapid and flexible bioprocessing in vaccine and therapeutic manufacturing, particularly post COVID-19, has enhanced the reliance on single-use bioprocess containers to accelerate production timelines while maintaining high sterility standards.
Growth in biopharmaceutical manufacturing and R&D activities: The expanding pipeline of biologics, including monoclonal antibodies and cell therapies, has significantly boosted demand for bioprocess containers in North America. Companies such as Sartorius AG have responded by expanding their manufacturing facilities in the U.S. to keep up with the increasing needs of contract manufacturing organizations (CMOs) and pharmaceutical firms for innovative and robust bioprocessing solutions. Consequently, investment in advanced bioprocess container products is expected to surge, supporting downstream and upstream processes efficiently.
Market Trends
Integration of advanced automation: Market leaders like Thermo Fisher Scientific have begun introducing bioprocess containers with RFID and IoT-enabled monitoring systems. This advancement improves process control, traceability, and compliance within biomanufacturing facilities. Automation not only streamlines operations but also enables real-time monitoring of critical parameters such as temperature, pH, and pressure, minimizing process deviations and human errors.
Sustainability and eco-friendly materials: Companies including Merck KGaA’s MilliporeSigma division are developing bioprocess containers using recyclable and biodegradable polymers to address environmental concerns associated with single-use plastics. Innovations in material science aim to create containers with minimized environmental footprint while maintaining product performance and safety. This aligns with the growing preference for sustainable practices in the life sciences sector, enhancing brand value and regulatory compliance.
Market Opportunity
Expanding cell and gene therapy production: The rapidly growing cell and gene therapy segment in North America presents significant opportunities for bioprocess container manufacturers. Key players such as Cytiva are focusing on catering to the specialized requirements of these advanced therapies, offering custom-configured bioprocess container solutions for aseptic operations and rapid scale-up.
Partnerships with CDMOs: Increased collaboration between bioprocess container companies and contract development and manufacturing organizations (CDMOs), such as Catalent, presents a lucrative growth avenue. These partnerships facilitate technology transfer, product innovation, and support for emerging biopharma startups seeking reliable bioprocessing solutions.
North America Bioprocess Containers Market Revenue (USD Million), 2020-2035
The market revenue chart illustrates consistent growth in the North America Bioprocess Containers Market from 2020 to 2035. Starting at USD 630 Million in 2020, the market experiences a robust increase, reaching USD 1,320 Million by 2025 and projected to climb to USD 3,610 Million by 2035. Growth is driven by factors such as the adoption of single-use containers, rising biologics and biosimilar production, and technological advancements. The chart highlights the strong upward trajectory and increasing investment in bioprocessing infrastructure throughout the forecast period.
North America Bioprocess Containers Market Share by Region (%) - 2025
The pie chart for 2025 reveals that the United States dominates the North America Bioprocess Containers Market with a substantial market share of 70%, attributed to its robust biopharmaceutical industry, strong investments in R&D, and the presence of key industry players. Canada holds a 15% share owing to increased biomanufacturing capacity and government support, while Mexico accounts for 8%. The remaining 7% is distributed among other regions, reflecting nascent market entry and emerging biopharma activity. This regional distribution underscores the stronghold of the U.S. as a prime market driver within North America.
Recent Developments in the North America Bioprocess Containers Market
In April 2024, Thermo Fisher Scientific launched its next-generation HyPerforma DynaDrive single-use bioprocess containers, featuring enhanced mixing capabilities and advanced sensor integration for continuous monitoring. These containers are designed to support large-volume cell culture and fermentation workflows, enabling biotech and pharmaceutical companies to increase productivity and ensure process robustness.
In March 2024, Merck KGaA (MilliporeSigma) announced a strategic expansion of its Burlington, Massachusetts facility, introducing new production lines dedicated to eco-friendly bioprocess container manufacturing. This investment aims to meet the increasing regional demand for high-quality and sustainable single-use supplies, supporting both clinical and commercial-scale biomanufacturing projects.
In February 2024, Cytiva entered into a collaboration with a leading North American CDMO for the supply of customized, sterile bioprocess containers tailored for cell and gene therapy applications. This partnership leverages Cytiva’s technological expertise to provide scalable and compliant solutions, accelerating the deployment of advanced therapeutics across the region.
By Type (2D Bioprocess Containers, 3D Bioprocess Containers, Tank Liners, Accessories, Others), By Application (Process Development, Upstream Processes, Downstream Processes, Media Preparation, Buffer Preparation, Others)
Press Releases